30
Nov
2008
Posted in I - Series B, Q - 2Q08, R - INTERNATIONAL, X - CRO
Oncodesign (France) a CRO and provider of preclinical oncology services, closed a $4.7 million Series B financing. Participants include Vizille Capital Innovation and Avenir Enterprises.
© 2012 OnBioVC An Indicium Data, LLC Company